A Combination of Glucagon-Like Peptide-1 Receptor Agonist and Dietary Intervention Could Be a Promising Approach for Obesity Treatment

被引：4
作者：
Lee, Chooi Yeng [1 ]
机构：
[1] Monash Univ Malaysia, Sch Pharm, Subang Jaya, Malaysia
来源：
FRONTIERS IN ENDOCRINOLOGY | 2021年 / 12卷
关键词：
combination therapy; diet; glucagon-like peptide-1 agonist; gut-brain axis; obesity; LAPAROSCOPIC SLEEVE GASTRECTOMY; WEIGHT-LOSS; GLUCOSE-INTOLERANCE; GLP-1; SECRETION; GASTRIC BYPASS; GUT MICROBIOTA; INFLAMMATION; INGESTION; GHRELIN; LEPTIN;
D O I：
10.3389/fendo.2021.748477
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：6
相关论文
共 50 条
  • [41] MRI measures of hypothalamic injury are associated with glucagon-like peptide-1 receptor agonist treatment response in people with hypothalamic obesity
    Perez, Francisco A.
    Elfers, Clinton
    Yanovski, Jack A.
    Shoemaker, Ashley H.
    Abuzzahab, M. Jennifer
    Roth, Christian L.
    DIABETES OBESITY & METABOLISM, 2021, 23 (07) : 1532 - 1541
  • [42] Predictors of weight-loss response with glucagon-like peptide-1 receptor agonist treatment among adolescents with severe obesity
    Nathan, B. M.
    Rudser, K. D.
    Abuzzahab, M. J.
    Fox, C. K.
    Coombes, B. J.
    Bomberg, E. M.
    Kelly, A. S.
    CLINICAL OBESITY, 2016, 6 (01) : 73 - 78
  • [43] Response to "An approach to insulin tapering and discontinuation after glucagon-like peptide-1 receptor agonist initiation"
    George, Jamie
    Farhat, Nada
    Thomas, Emily
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (22) : 1979 - 1980
  • [44] Glucagon-like peptide-1 receptor agonist regulates fat browning by altering the gut microbiota and ceramide metabolism
    Lin, Ke
    Dong, Chunyan
    Zhao, Binyan
    Zhou, Bailing
    Yang, Li
    MEDCOMM, 2023, 4 (06):
  • [45] Effect of the glucagon-like peptide-1 receptor agonist liraglutide, compared to caloric restriction, on appetite, dietary intake, body fat distribution and cardiometabolic biomarkers: A randomized trial in adults with obesity and prediabetes
    Silver, Heidi J. J.
    Olson, Dianna
    Mayfield, Dustin
    Wright, Patricia
    Nian, Hui
    Mashayekhi, Mona
    Koethe, John R. R.
    Niswender, Kevin D. D.
    Luther, James M. M.
    Brown, Nancy J. J.
    DIABETES OBESITY & METABOLISM, 2023, 25 (08) : 2340 - 2350
  • [46] Glucagon-Like Peptide-1 Receptor in the Brain: Role in Neuroendocrine Control of Energy Metabolism and Treatment Target for Obesity
    Lockie, S. H.
    JOURNAL OF NEUROENDOCRINOLOGY, 2013, 25 (07) : 597 - 604
  • [47] Glucagon-like peptide-1 and glucagon-like peptide-2
    Baggio, LL
    Drucker, DJ
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 18 (04) : 531 - 554
  • [48] Glucagon-like peptide-1 receptor agonist treatment reduces beta cell mass in normoglycaemic mice
    Ellenbroek, J. H.
    Tons, H. A. M.
    van Meeteren, M. J. A. Westerouen
    de Graaf, N.
    Hanegraaf, M. A.
    Rabelink, T. J.
    Carlotti, F.
    de Koning, E. J. P.
    DIABETOLOGIA, 2013, 56 (09) : 1980 - 1986
  • [49] Glucagon-like peptide-1 receptor agonist treatment reduces beta cell mass in normoglycaemic mice
    J. H. Ellenbroek
    H. A. M. Töns
    M. J. A. Westerouen van Meeteren
    N. de Graaf
    M. A. Hanegraaf
    T. J. Rabelink
    F. Carlotti
    E. J. P. de Koning
    Diabetologia, 2013, 56 : 1980 - 1986
  • [50] Equine glucagon-like peptide-1 receptor physiology
    Kheder, Murad H.
    Bailey, Simon R.
    Dudley, Kevin J.
    Sillence, Martin N.
    de Laat, Melody A.
    PEERJ, 2018, 6
12345